Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL EQUITY
Total Equity HALO - Halozyme Therapeutics, Inc.
364 M
LAST VALUE
46.38%
2 YEAR CAGR
31.72%
5 YEAR CAGR
24.29%
10 YEAR CAGR